Theratechnologies Inc T.TH

Analysts target

[Adonis]

Do you think analysts will increase their SP target after this PR?

[SPCEO1]

I am not even sure any of the analysts covering the stock will write a report on it. None has so far. It would be quite a surprise to me if any price targets were raised on this info as it is not the kind of news analysts normally react to. Now, this is highly technical medical stuff, so maybe there is more to it than I realize. Basically, it is good news and it makes Egrifta look more like MDGL

[qwerty22]

I'd agree with you it doesn't speak directly too endpoints in clinical trials and it's not the type of info that gets regulators basing decisions on. I think in NASH wrt efficacy they mostly base that on the histological endpoints. I do think it's supportive of that decision making process, it adds depth to the mechanistic processes and so gives you more comfort in the decision but

[SPCEO1]

I wish you were right on the reasons for the stock price jumps but I suspect you are not. The market is currently in a bubble. Nonsense can be found all over the place but you need not look any further than CYDY for the best example of bubble behavior. If you are a company that puts out frequent press releases, chances aer you stock is hopping. That is not because of insightful analysis being

[Scioto]

good insight. The after hours trading the other night was nuts. The market is frothy and a lot of momentum manipulation on news. You may remember in the spring I encouraged us to push news out on the company to sites like stock twits. Now granted that's not the same level of evaluation and stock understanding as stock house but it is a popular site in America. Following has grown. There were

[jfm1330]

When you look at Cytodyn, it did not go from 0.30$ to 8,77$ because of algorithms. The US market is just more reactive and speculative. Much more day trading. The amplitude of the price changes is much larger and it goes both ways. Big rise on positive news, but also huge drop on negative ones. That being said. Did we learn something yesterday? The answer is yes. Epigenetics is a reality that is

[SPCEO1]

CYDY has been pushed higher by retail investors getting sucked in by the very questionable claims the company is making. But it has had some algos working it too. I think it traded 53 million shares one day recently - that certainly wasn't retail and it also was unlikely to be institutions either. THTX 's 7 million shares traded on the day of the cancer press release make it look like a